China approves St. Jude-Abbott merger with conditions

• China approves the merger between Abbott Laboratories (NYSE:ABT) and St. Jude Medical (NYSE:STJ) with conditions.
• The commerce ministry says St. Jude must sell it vascular closure device business to Terumo as part of the agreement.